Background REGEN-COV (previously known as REGN-COV2), a combination of the monoclonal
antibodies casirivimab and imdevimab, has been shown to markedly reduce the risk of …

Importance Easy-to-administer anti–SARS-CoV-2 treatments may be used to prevent
progression from asymptomatic infection to symptomatic disease and to reduce viral carriage. …

Background Immune activation persists despite suppressive antiretroviral therapy (ART) in
human immunodeficiency virus (HIV) infection and predicts non-Acquired Immune Deficiency …

While new vaccines for SARS-CoV-2 are authorized based on neutralizing antibody (nAb)
titer against emerging variants of concern, an analogous pathway does not exist for …

Objective: Evaluate the efficacy and safety of subcutaneous casirivimab and imdevimab
antibody combination (REGEN-COV) to prevent progression from early asymptomatic SARS-…

Background There is an unmet need for COVID-19 prevention in patient populations who
have not mounted or are not expected to mount an adequate immune response to complete …

Persons with HIV infection (PWH) have increased risk for cardiovascular disease (CVD), but
the underlying mechanisms remain unclear. Coronary thrombosis is known to provoke …

IgA plays an important early neutralizing role after SARS-CoV-2 infection. Systemically
administered vaccines typically produce an IgM/IgG predominant response. We evaluated the …

Background Subcutaneous immunotherapy (SCIT) has been proven as an effective therapy
against some allergens for seasonal allergic rhinitis (SAR) patients unresponsive to …

Background The efficacy of an allergen-specific IgG cocktail to treat cat allergy suggests that
allergen-specific IgG may be a major protective mechanism elicited by allergen …